| Report ID |
106728 |
| Drug Identification Number |
02455609 |
| Brand name |
CHOLESTYRAMINE-ODAN |
| Common or Proper name |
Cholestyramine for Oral Suspension, USP |
| Company Name |
ODAN LABORATORIES LTD |
| Market Status |
MARKETED |
| Active Ingredient(s) |
CHOLESTYRAMINE RESIN |
| Strength(s) |
4G |
| Dosage form(s) |
POWDER FOR SUSPENSION |
| Route of administration |
ORAL |
| Packaging size |
30 x 4g |
| ATC code |
C10AC |
| ATC description |
LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage |
Delay in shipping of the drug. |
| Anticipated start date |
|
| Actual start date |
2020-02-19 |
| Estimated end date |
2020-04-27 |
| Actual end date |
2020-04-09 |
| Shortage status |
Resolved |
| Updated date |
2020-04-13 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
info@odanlab.com
Tel.: 1-800-387-9342
Fax: 1-800-329-6326 |
